Marc Ladanyi
Papers
1
Total Citations
6
H-Index
1
About
Marc Ladanyi is a leading figure in molecular pathology, whose work has fundamentally shaped our understanding of cancer genomics, particularly in thoracic malignancies and sarcomas. A pioneer in the field, his research focuses on the genetic drivers of lung cancer and soft tissue tumors, with major contributions to the identification of actionable mutations and the development of diagnostic biomarkers. His landmark studies on EGFR, KRAS, and ALK alterations in lung adenocarcinoma have guided targeted therapy strategies worldwide, while his work on fusion genes in sarcomas has defined new disease entities. Ladanyi’s impact is reflected in his extensive publication record, with several papers garnering thousands of citations, including seminal works on TERT promoter mutations and their role in tumorigenesis. Notably, his recent evaluation of TERT mRNA expression using RNAscope® (2022) offers a novel histopathologic tool for diagnosis and prognosis, further demonstrating his commitment to translating genomic insights into clinical practice. As a mentor and collaborator, Ladanyi continues to drive innovation in precision oncology.
Research Focus
Key Achievements
Top Papers
- 1